Riskpilot← Back to searchSign inGet full accessFRESK FYSIOTERAPI AS
ASActiveOrg 917195110Vennalivegen 6, 7670 InderøyPhysiotherapy activities · NACE 8695Est. 20160 employees
Revenue 2024
NOK 428K
-15% vs 2023
EBITDA margin
6.8%
-76% vs 2023
Equity ratio
40.0%
Financial strength
Net profit 2024
NOK 12K
-84% vs 2023
| Revenue | NOK 428K | -15% |
| EBITDA | NOK 29K | -76% |
| Net profit | NOK 12K | -84% |
| Total assets | NOK 159K | -6% |
| Equity | NOK 64K | +24% |
| Employees | 0 | — |
Legal name
FRESK FYSIOTERAPI AS
Org number
917195110
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
20. mai 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Fysioterapivirksomhet, samt det som naturlig står i forbindelse med dette.
Address
Vennalivegen 6, 7670 Inderøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 293 | 345 | 390 | 502 | 428 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −42 | −74 | 18 | 123 | 29 |
| Depreciation & amort. | −15 | −19 | −21 | −24 | −12 |
| EBIT | −57 | −93 | −2 | 99 | 17 |
| Net financials | −0 | 0 | −0 | −1 | −1 |
| Profit before tax | −57 | −93 | −3 | 99 | 16 |
| Tax | −13 | −20 | −1 | 22 | 3 |
| Net profit | −45 | −73 | −2 | 77 | 12 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 137 | 160 | 165 | 169 | 159 |
| Equity | 49 | −23 | −25 | 51 | 64 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 88 | 184 | 190 | 118 | 96 |
| Total debt | 88 | 184 | 190 | 118 | 96 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20202024
Equity ratio
40.0%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
19.2%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20202024
Asset turnover
2.68×
This company
1.12×
Market median
+139% vs market
20202024
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TR Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Deputy Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ketil Sten As
FRESK FYSIOTERAPI AS Board members of FRESK FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tore Rein | Chief Executive Officer | 0 companies |
| Monica Helden Flatås | Chairman | 0 companies |
| Olav Wohlen | Board of Directors | 0 companies |
| Ketil Sten | Deputy Chairman | 0 companies |